Keywords: generex, enters, 25m, oralin, deal, canadas, biotechnology

Generex enters $25M Oralin deal

Article | 05 July 2004

Print This

Canadas Generex Biotechnology, a leader in the area of buccal drugdelivery, announced today that it has signed a letter of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in